首页> 外文期刊>Saudi Pharmaceutical Journal >Experimental and theoretical study on structure-tautomerism among edaravone, isoxazolone, and their heterocycles derivatives as antioxidants
【24h】

Experimental and theoretical study on structure-tautomerism among edaravone, isoxazolone, and their heterocycles derivatives as antioxidants

机译:埃达拉夫酮,异恶唑酮及其杂环衍生物作为抗氧化剂的实验与理论研究

获取原文
           

摘要

Edaravone is a heterocyclic pyrazolone compound. It has pronounced effect against free radicals, however renal and hepatic disorders have been reported. Isoxazolones are considered bioisosteric analogues of pyrazolones and may have comparable properties. Thus, we investigated the structural and electronic influences for edaravone, isoxazolone, and their tautomers on antioxidant process. Structure and tautomerism study among edaravone, isoxazolone and their heterocycles derivatives were related to antioxidant mechanisms by using the hybrid DFT method B3LYP with the basis sets 6-31++G(2d,2p). The C H tautomer was the most stable and energetically favored among them. Intramolecular N H N hydrogen bonds and polar medium were responsible for the low energy differences among all possible tautomers. N H tautomers in both systems proved to be better antioxidant by SET (single electron transfer), while O H tautomers were better antioxidant on HAT (homolytic hydrogen atom transfer) mechanism. Theoretical calculation showed that edaravone is more potent than phenylisoxazolone, however, both has similar antioxidant scavenging on experimental DPPH. The carbonyliminic system played a very important role in the antioxidant activity for both studied classes.
机译:埃达伐是一种杂环吡唑啉酮化合物。它对自由基具有明显的影响,但报道了肾病和肝脏障碍。 Isoxazolones被认为是吡唑啉酮的生物话组织类似物,并且可能具有可比性。因此,我们研究了对抗氧化过程中埃达拉夫酮,异恶唑酮及其互氧化剂的结构和电子影响。通过使用基础组6-31 ++ G(2D,2P)的杂交DFT方法B3LYP,抗鲕酮,异恶唑酮及其杂环衍生物之间的结构和互氧化性衍生物与抗氧化机制有关。 C H互变异构成它们中最稳定和充满活力的青睐。分子内N H N氢键和极性介质负责所有可能的互变异构体之间的低能量差异。 N H互变异构成通过设定(单电子转移)被证明是更好的抗氧化剂,而O H互变异构体是更好的帽子(均解氢原子转移)机制的抗氧化剂。理论计算表明,埃达拉夫酮比苯二氧苯胺唑酮更有效,然而,两者都在实验DPPH上具有类似的抗氧化剂清除。羰基丙氨酸系统在研究阶级的抗氧化活性中起着非常重要的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号